Embed Size (px)
Citation preview
#
4
14
19
29
37
46
52
59
87
91
110
128
129
143
147
FECHA / DATE
28 de Octubre
28 de Octubre
27 de Octubre
28 de Octubre
28 de Octubre
28 de Octubre
27 de Octubre
28 de Octubre
27 de Octubre
27 de Octubre
28 de Octubre
28 de Octubre
28 de Octubre
27 de Octubre
28 de Octubre
October 28th
October 28th
October 27th
October 28th
October 28th
October 28th
October 27th
October 28th
October 27th
October 27th
October 28th
October 28th
October 28th
October 27th
October 28th
HORA / HOUR
09:00 A.M.
09:00 A.M.
15:10 P.M.
09:00 A.M.
12:00 P.M.
12:00 P.M.
15:10 P.M.
15:30 P.M.
14:50 P.M.
17:05 P.M.
15:30 P.M.
15:30 P.M.
15:30 P.M.
17:05 P.M.
11:20 A.M.
FECHA / DATE
Parallel Sesion E
Parallel Sesion E
Parallel Sesion B
Parallel Sesion E
Parallel Sesion H
Parallel Sesion H
Parallel Sesion A
Parallel Sesion J
Parallel Sesion B
Parallel Sesion D
Parallel Sesion J
Parallel Sesion I
Parallel Sesion I
Parallel Sesion C
Parallel Sesion G
T I T U L O / T I T T L E Medical devices recall: A comparison of cardiology medical devices recall in the United States and the European Union for 2018.
Application of Qualitative method to detect signals andmanage alerts in pharmacovigilance: Moroccan experience.
#MedSafetyWeek: joining forces on social media to raiseADR awareness.
Digital tools for the communication of risk minimization measures for medicines.
Impact and Characterization of the Drug Related Problems Reported by Polymedicated Inpatients with Prolonged Stays.
Initiave to increase PV awareness and support access tomedication for the patient.
Current status and reflections about cardiotoxicity related to Traditional Chinese Medicine Drugs.
Patient counseling practice among healthcare professionals in Saudi Arabia: its impact on patient safety.
Systematic Instructions for Haematological Monitoring in Summary of Product Characteristics – what constitutes good practice?
Vaccines safety in children and in general population:a pharmacovigilance study on adverse events followingimmunization in Italy.
Medication errors and genetic factors as possible causes of therapeutic failures and adverse drug reactions in a group of Colombian epilepsy patients.
The impact of Pharmacovigilance in Patient SupportPrograms for Orphan Diseases, experience in Colombia.
Differences in Pharmacovigilance Regulatory Requirements in Latin America countries (LATAM).
Creation of an Innovation Function in Pharmacovigilance.
How the Romanian women perceive the advantages and risks of the contraceptives?
#
1
2
3
5
6
7
8
9
10
11
12
13
15
16
17
T I T U L O / T I T T L E
The current status of Korea Institute of Drug Safety and Risk Management-Korea Adverse Event ReportingSystem Database in the Republic of Korea.
Antibiotic drugs and unresolved sensory side effects: analysis of Eudravigilance database of suspected adverse drug reaction reports.
Impact on the detection of DRPs when including technical staff within the pharmacoterapeutic monitoringprogram in the pharmaceutical service.
Integrated use of spontaneous reports of adverse drug reactions and observational healthcare data in signal assessment.
Activity report of the pharmacovigilance unit of the Ibn Sina Rabat hospital : National PharmacovigilanceNotification Day 23nd May 2019.
Upper gastrointestinal bleeding and risk factors.
Drug interactions identified through active pharmacovigilance in an Internal Medicine emergency service ofa tertiary care hospital: a cross sectional study.
Adverse drug reactions related to extemporaneously compounded medicines.
Anticoagulant therapy and risk of bleeding in patients with atrial fibrillation of four Italian Regions:the TYRION study.
Online discussion forums in Bulgaria as a source of adverse drug reactions reports for sertraline.
The role of the clinical pharmacist in the detecting of suspected ADR in a secondary level hospital.
Survey of healthcare professionals on adverse drug reaction reporting, communication, and medicinesregulation in New Zealand.
Indication of use of omeprazole in elderly patients with Alzheimer’s disease.
Minimization of the risk after an intervention in a cohort of patients with dispensation of diacerein oral in two Colombian areas, 2018-2019.
The use of data mining in detecting Adverse Drug Reaction (ADR) in social media.
#
18
20
21
22
23
24
25
26
27
28
30
31
32
33
34
T I T U L O / T I T T L E
Comparison of laboratory threshold criteria in drug-inducedliver injury detection algorithms in the electronic medical records.
Impact Of Pharmacovigilance Education on Adverse Drug Reaction Reporting Among Nursing Staff at a Major Tertiary Hospital in Riyadh, Saudi Arabia.
Communicating the Value of Pharmacovigilance, Above and Beyond Compliance.
Recommendations by the Tuscan Health Authority to use infliximab-biosimilar in the clinical practice:safety impact.
Retrospective study of adverse effects of drugs: experience of the regional pharmacovigilance unit of theuniversity hospital Hassan II of Fez, Morocco.
Drug label changes through Serious Adverse Event review system in the Republic of Korea.
Effect of the pharmacists in antimicrobial stewardship (AMS) programs in a high complexity hospital inColombia between 2016-2018.
Medication storage knowledge, attitude and practice among diabetic patients and their association with blood glucose control.
Online discussion forums in Bulgaria as a source of adverse drug reactions reports for omeprazole andfamotidine.
Disproportionality analysis in small national databases: robust results but questionable utility.
Risk and Signals of Urinary Tract Infections Among Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors:Analyses of Post Marketing FDA Adverse Event Reporting System (FAERS) Database, 2013-2018.
Fast, robust and flexible - statistical screening of national subsets in VigiBase through VigiLyze.
Colistin-induced nephrotoxicity in adult population during intravenous therapy.
Pharmacovigilance of Antivenoms in Toxicological Emergencies.
Obtaining Real Time Estimates of Commercial Patient Exposure.
#
35
36
38
39
40
41
42
43
44
45
47
48
49
50
51
T I T U L O / T I T T L E
HPV Vaccination Program in Romania – Strategies and Results.
Potential adverse drug events in elderly patients.
Safety of inulin: combining several sources for Pharmacovigilance purpose.
Impact of the pharmacist’s intervention in the standardization of the dose of Metamizole as perioperativeanalgesic.
A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies.
Evolution of Communication Plan REMS Programs.
Tramadol and Hyponatraemia – new aspects of an old signal.
Fluoroquinolones and risk of tendinopahty: a systematic review and meta-analysis of observational studies.
Activity report of hospital pharmacovigilance: case of the National Institute of Oncology of Rabat.
Indapamide-induced (acute hypokalemic) rhabdomyolysis.
Interest of a bidisciplinary collaboration: Experience of 4 month dermatology-pharmacovigilance consultation.
Local tolerance during administration of two brands of subcutaneous somatropin.
REMS Technology Innovation: Results of a Pharmacy Business to Business (B2B) Pilot.
Vigilance of Cannabis Products in Canada.
DRUG-PROBLEMS IN A NEWBORN NEONATAL INTENSIVE CARE UNIT IN II LEVEL HOSPITAL IN BOGOTÁDURING A PERIOD OF 6 MONTHS.
#
53
54
55
56
57
58
60
61
62
63
64
65
66
67
68
T I T U L O / T I T T L E
A pilot intensive safety surveillance scheme for medicines under additional monitoring used in the treatmentof cancer.
Promoting Spontaneous Adverse Event Reporting in Morocco: The national Reporting Day.
Knowledge, attitude and perception of medicine students with respect to the use of antibiotics and theirresistances.
Use of social media in pharmacovigilance for patient empowerment and spontaneous reporting:a systematic review.
Acute pulmonary edema in pediatric oncology: pharmaceutical vigilance.
Identification of communication opportunities in the report process of adverse reactions.
Adverse reactions associated with the use of biotechnological drugs in Colombia.
Monitoring of adverse drugs reactions through statistical process control charts in the National Institute ofCancerology of Colombia.
Fluoroquinolones and tendon ruptures: An analysis of reported cases in relation to exposed patients in Germany.
Green urine after propofol infusion.
Update of pure red cell aplasia associated to Hemax®, a biosimilar epoetin alfa.
Materiovigilance in a pediatrics hospital: about two cases.
Develop a semantics & graph based Pharmacovigilance knowledge management approach to enable datamining and decision support.
Parkinsonism associated with Gabapentinoid drugs: an observational post marketing study.
DESCRIPTION OF ADVERSE REACTIONS FOUND IN PATIENTS WHO RECEIVED VORICONAZOLE IN THEUNIVERSITY IPS FROM THE PERIOD OF MAY 2013 TO MARCH 2015.
#
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
T I T U L O / T I T T L E
Lessons learned from a fatal medication error related to Rocuronium in a newborn, 2018, Morocco.
How Portuguese users of social media communicate with Pharmacovigilance Unit Facebook pages?
Use of escitalopram associated with mastalgia in a middle-aged woman with generalized anxiety disorder:a case report and literature review.
The Impact of New Chemical Entity Project on Signal Detection in Saudi Arabia.
Drug-related problems surveillance inside San VicenteFundacion Hospital.
Cost of Potentially Inappropriate Medications in French Regional Residential Care Homes for Elderly.
Post-marketing evaluation of SC interferon beta 1a (Blastoferon®) in Argentina.
Develop an Emergent Behavioral Capability model to enable Transformational Programs in Pharmacovigilance and beyond.
Anti-tumor necrosis factor drugs and risk of lymphoma in patients with inflammatory bowel disease.
Listening social media for pharmacovigilance objectives: which usefulness?
Therapeutic Drug Monitoring in Morocco: experience of Centre Anti Poison et de Pharmacovigilance.
Bleomycin-induced flagellate erythema: A report of 12 cases.
Seasonal Influenza Vaccination: Knowledge, Attitudes and Behaviors in Pregnant Women and Health CareProfessionals - Morocco, 2018.
Safety & Risk minimization of CAR T cell therapies: US & EU Perspectives.
Analysis of the recording of a history of drug allergies and adverse drug reactions in routine prescribing practice in a UK teaching hospital.
#
84
85
86
88
89
90
92
93
94
95
96
97
98
99
100
T I T U L O / T I T T L E
Establishing dose-banding limits for children’s medications.
Pharmaceutical analysis of handwritten medical prescriptions from doctors in pediatrics hospital.
Use of triggers tool to detect adverse drug reactions in an adult emergency department at a Brazilian University Hospital.
PHARMACOVIGILANCE TEACHING IN BRAZILIAN PUBLIC UNIVERSITIES.
Drug-related problems in older patients - a pilot study in Portuguese primary care centers.
PILOT STUDY FOR BULGARIA ADDRESSING MEDICAL DOCTORS AND PHARMACISTS PERCEPTIONS FORMEDICINES RECLASSIFICATION SAFETY ISSUES.
Analysis of RMP summaries for approved innovator products: Swissmedic perspective.
Patients’ Knowledge of ADR and its notification in Colombia: a quantitative study.
Medication errors patient reporting assessment within Moroccan pharmacovigilance database.
Impact of a robust team of pharmacists in the active pharmacovigilance of a public university hospital in Bogotá.
DRUG-RELATED INCIDENTS INVOLVING CHILDREN IN BRAZILIAN UNIVERSITY HOSPITALS.
Knowledge, Attitude and Practice of Health Professionals towards Pharmacovigilance in Women.
A Biological Network Convergence Approach for Interpreting Herb-Drug Interaction-Related Adverse Reactions.
EDUCATIONAL INTERVENTION FOR THE STRENGTHENING OF THE CAPABILITIES OF HEALTH PROFESSIONALS IN PHARMACOVIGILANCE FOR THE APPLICATION OF THE REGULATORY FRAMEWORK IN EL SALVADOR.
USING A MOBILE-PHONE BASED SYSTEM FOR SURVEILLANCE OF ADVERSE EVENTS IN THE ROLL OUT OFDOLUTEGRAVIR: A PILOT PROJECT.
#
101
102
103
104
105
106
107
108
109
111
112
113
114
115
116
T I T U L O / T I T T L E
Leveraging big data techniques to support medical review in pharmacovigilance.
Characterization of adverse drugs events in elderly identified in a hospital between 2017 and 2018, in Bogotá, Colombia.
A Rational Usage of Combined Using of Herbal Medicines and Synthetic Medicines: A Time Interval Window Research.
Interception and management of medication errors at the pharmacy of Ibn Sina Hospital Rabat - MOROCCO: Case of a fatal error.
Active Pharmacovigilance to determine delayed adverse drug reactions in Mexican childhood cancer survivors.
Profile of Central Nervous System Adverse Reactions Associated with Artesunate and Amodiaquine Combination.
Improved Pharmacovigilance in management of late-onset side effects.
Regulatory landscape of pharmacovigilance in Latin America. Comparative review of the pharmacovigilance regulation in LATAM countries versus International Standards from ICH.
RISK MANAGEMENT IN DRUG INTERACTIONS.
Establish active pharmacovigilance network based on common data model in Korea.
Effectiveness and safety of standard and reduced dose rivaroxaban compared to vitamin K antagonists inpatients at high risk of bleeding or stroke.
Performance of sodium polystyrene and serum of potassium levels as triggers to detect drug-inducedhyperkalemia.
Active monitoring of newly standardized medication with less than five years in commercialization.
A Protocol for systematic review of Guidelines for antibiotics prescription in respiratory tract infections.
Pan American Countries – Harmonisation of Drug Safety Risk Management Planning and Communication.
#
117
118
119
120
121
122
123
124
125
126
127
130
131
132
133
T I T U L O / T I T T L E
Cardiac Toxicity of Trastuzumab in Non-Metastatic Breast Cancer HER2 Positive – The Experience of CountyOncology Clinic Sibiu, Romania.
Example of the contribution of pharmacogenetics to pharmacovigilance in Morocco: Prevalence of the CYP2C19*2 polymorphism and Clopidogrel resistance in Moroccan population.
Analysis of Traditional Chinese Medicine Safety Information Issued by China Adverse Drug Reaction Information Bulletin.
Use of antipsychotics for Psychological and Behavioral Symptoms of Dementia in elderly with Alzheimer’s disease.
A Model for Federated, Near Real-Time Individual Case Safety Report Compliance Monitoring.
Adverse effects induced by imatinib (Cémivil®): About 4 cases at Ibn sina hospital in Rabat.
Use of medicinal plants in oncology and their adverse effects.
The anti-TNF drugs and the risk of lymphoma, skin cancer and melanoma: a signal detection analysis.
SEVERE CUTANEOUS ADVERSE REACTIONs (SCARs): THE ANALYSIS OF DRUG INJURY RELIEF APPLICATIONSIN TAIWAN.
ADHD Medications and Psychotic Disorders.
Overview of Pharmacovigilance System in Colombia: Present and principal challenges.
GENDER-RELATED DIFFERENCES OF ADVERSE DRUG REACTIONS IN THE MOROCCAN POPULATION.
Smuggling in Morocco: a real public health problem.
Proposal of an exclusive pharmacovigilance discipline for health science curricula in Brazil.
Neonatal Drug Withdrawal Syndrome and Gabapentinoids.
#
134
135
136
137
138
139
140
141
142
144
145
146
T I T U L O / T I T T L E
Cutaneous adverse drug reactions in a third level center: an active pharmacovigilance institutional programin Colombia.
The Analysis and Enlightenment of DSMB Application in Pediatric Drugs Clinical Trials.
French Levothyrox® Crisis: Retrospective Analysis of French web forums dedicated to thyroid pathology.
PHARMACOVIGILANCE RISK ASSESSMENT TO RADIOPHARMACEUTICALS.
Acute generalized exanthematous pustulosis (AGEP) inducted by penicillin.
SAFETY OF DRUG PACKAGING: A RISK MANAGEMENT PLAN IS NEEDED.
Cardiovascular adverse drug reactions of ibrutinib, idelalisib, acalabrutinib and venetoclax used in chroniclymphocytic leukemia: Signal detection by disproportionality analysis from VigiBase®.
Piperacillin-Tazobactam induced Neutropenia: Report of 4 cases and review of the Literature.
A Study of the Causality, Severity and Preventability of Antibiotics Adverse Drug Reactions Reported to the Iraqi Pharmacovigilance Database (2010-2017).
Terlipressin induced Hyponatremia: Report of 3 Cases and description of associated risk Factors.
Trastuzumab emtansine induced acute pancreatitis: report of two cases and review of literature.
DRUG-ASSOCIATED ANAPHYLACTIC SHOCK: THE ANALYSIS OF DRUG INJURY RELIEF APPLICATIONSIN TAIWAN.
